These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36399824)

  • 1. Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids.
    Zhou Y; Suo W; Zhang X; Yang Y; Zhao W; Li H; Ni Q
    Biomed Pharmacother; 2023 Jan; 157():114025. PubMed ID: 36399824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary flavonoids prevent diabetes through epigenetic regulation: advance and challenge.
    Han S; Luo Y; Liu B; Guo T; Qin D; Luo F
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):11925-11941. PubMed ID: 35816298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in diabetic cardiomyopathy.
    Ma X; Mei S; Wuyun Q; Zhou L; Sun D; Yan J
    Clin Epigenetics; 2024 Apr; 16(1):52. PubMed ID: 38581056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Approach of Flavonoid in Ameliorating Diabetic Cardiomyopathy by Targeting Mitochondrial-Induced Oxidative Stress.
    Sapian S; Taib IS; Latip J; Katas H; Chin KY; Mohd Nor NA; Jubaidi FF; Budin SB
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics of methylation modifications in diabetic cardiomyopathy.
    Hao J; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1119765. PubMed ID: 37008904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and diabetic cardiomyopathy.
    Singh GB; Sharma R; Khullar M
    Diabetes Res Clin Pract; 2011 Oct; 94(1):14-21. PubMed ID: 21696841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy.
    Asrih M; Steffens S
    Cardiovasc Pathol; 2013; 22(2):117-25. PubMed ID: 22951386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms in cardiovascular complications of diabetes: towards future therapies.
    Damiano G; Rinaldi R; Raucci A; Molinari C; Sforza A; Pirola S; Paneni F; Genovese S; Pompilio G; Vinci MC
    Mol Med; 2024 Sep; 30(1):161. PubMed ID: 39333854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Role of Flavonoids in Ameliorating Diabetic Cardiomyopathy via Alleviation of Cardiac Oxidative Stress, Inflammation and Apoptosis.
    Jubaidi FF; Zainalabidin S; Taib IS; Hamid ZA; Budin SB
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNA-mediated endothelial-to-mesenchymal transition in human diabetic cardiomyopathy, potential regulation by DNA methylation.
    Wang E; Chen S; Wang H; Chen T; Chakrabarti S
    Cardiovasc Diabetol; 2023 Nov; 22(1):303. PubMed ID: 37924123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in the development of diabetic cardiomyopathy.
    Pepin ME; Wende AR
    Epigenomics; 2019 Apr; 11(5):469-472. PubMed ID: 30895816
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel insights into DNA methylation and its critical implications in diabetic vascular complications.
    Zheng J; Cheng J; Zhang Q; Xiao X
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28183874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update: the role of epigenetics in the metabolic memory of diabetic complications.
    Chen Z; Malek V; Natarajan R
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F327-F339. PubMed ID: 38961840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galangin attenuates diabetic cardiomyopathy through modulating oxidative stress, inflammation and apoptosis in rats.
    Abukhalil MH; Althunibat OY; Aladaileh SH; Al-Amarat W; Obeidat HM; Al-Khawalde AAA; Hussein OE; Alfwuaires MA; Algefare AI; Alanazi KM; Al-Swailmi FK; Arab HH; Mahmoud AM
    Biomed Pharmacother; 2021 Jun; 138():111410. PubMed ID: 33752930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms.
    Xiao M; Tang Y; Wang S; Wang J; Wang J; Guo Y; Zhang J; Gu J
    Front Endocrinol (Lausanne); 2021; 12():598008. PubMed ID: 34349728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics: deciphering its role in diabetes and its chronic complications.
    Villeneuve LM; Reddy MA; Natarajan R
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):451-9. PubMed ID: 21309809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives.
    Tao H; Song ZY; Ding XS; Yang JJ; Shi KH; Li J
    Endocrine; 2018 Nov; 62(2):281-291. PubMed ID: 30054866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.
    Kadakol A; Malek V; Goru SK; Pandey A; Gaikwad AB
    Indian J Pharmacol; 2017; 49(5):348-356. PubMed ID: 29515275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.
    Link A; Balaguer F; Goel A
    Biochem Pharmacol; 2010 Dec; 80(12):1771-92. PubMed ID: 20599773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modifications in metabolic memory: What are the memories, and can we erase them?
    Chen Z; Natarajan R
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C570-C582. PubMed ID: 35785987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.